granisetron kabi 3mg/ 3ml vial / each

DESCRIPTION:

Granisetron Kabi, available in a 3mg/3mL vial, is a medication used to prevent and treat nausea and vomiting, particularly those induced by chemotherapy or radiation therapy.

• Active Ingredient: Each vial of Granisetron Kabi contains 3mg of the active ingredient, granisetron hydrochloride. Granisetron belongs to a class of medications known as serotonin 5-HT3 receptor antagonists, which work by blocking the action of serotonin, a neurotransmitter involved in the sensation of nausea and vomiting.
• Indications: Granisetron Kabi is primarily indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy or radiation therapy in cancer patients. It is particularly effective in preventing acute and delayed chemotherapy-induced nausea and vomiting.
• Dosage and Administration: Granisetron Kabi is typically administered as an injection, either intravenously (IV) or intramuscularly (IM), depending on the healthcare provider's preference and the patient's condition. Each vial contains 3mg of granisetron hydrochloride in a 3mL solution. The dosage and frequency of administration may vary depending on factors such as the type of chemotherapy regimen, the severity of symptoms, and the patient's response to treatment.
• Onset and Duration of Action: Granisetron Kabi has a rapid onset of action, usually within 30 minutes of administration. It provides effective control of nausea and vomiting during the acute phase of chemotherapy and can also prevent delayed symptoms. The duration of action may last up to 24 hours, providing sustained relief for patients undergoing chemotherapy.